PGIM Jennison Health Sciences Fund - Class R6 (PHLQX)
Fund Assets | 1.36B |
Expense Ratio | 0.77% |
Min. Investment | $1,000 |
Turnover | 79.00% |
Dividend (ttm) | 5.44 |
Dividend Yield | 12.99% |
Dividend Growth | 184.56% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 20, 2024 |
Previous Close | 42.69 |
YTD Return | -2.39% |
1-Year Return | -0.60% |
5-Year Return | 53.90% |
52-Week Low | 38.29 |
52-Week High | 55.21 |
Beta (5Y) | n/a |
Holdings | 45 |
Inception Date | Jan 27, 2016 |
About PHLQX
The PGIM Jennison Health Sciences Fund Class R6 is an actively managed sector equity fund aimed at achieving long-term capital appreciation. It focuses on investments in companies within the health sciences sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. Designed primarily for institutional investors, this fund benefits from a lower expense ratio compared to other share classes. It actively seeks out companies with strong growth potential and innovative products or services, making it a strategic investment option for those looking to capitalize on the rapidly evolving healthcare industry. The fund's diversified portfolio includes a range of healthcare-related companies, positioning it as a key player in the financial market for health sector investments.
Performance
PHLQX had a total return of -0.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.00%.
Top 10 Holdings
57.84% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 14.60% |
Prudential Govt Money Mkt Fd | n/a | 10.96% |
Vertex Pharmaceuticals Incorporated | VRTX | 4.95% |
argenx SE | ARGX | 4.85% |
Neurocrine Biosciences, Inc. | NBIX | 4.78% |
AstraZeneca PLC | AZN | 4.64% |
Thermo Fisher Scientific Inc. | TMO | 3.58% |
Novo Nordisk A/S | NVO | 3.50% |
Alnylam Pharmaceuticals, Inc. | ALNY | 3.15% |
UnitedHealth Group Incorporated | UNH | 2.85% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 20, 2024 | $5.44419 | Dec 20, 2024 |
Dec 20, 2023 | $1.91322 | Dec 20, 2023 |
Dec 20, 2022 | $0.61624 | Dec 20, 2022 |
Dec 20, 2021 | $14.02528 | Dec 20, 2021 |
Dec 20, 2019 | $1.43164 | Dec 20, 2019 |
Dec 20, 2018 | $4.77761 | Dec 20, 2018 |